A multifunction murine Col4a1 allele reveals potential gene therapy parameters for Gould syndrome

Authors:
Publisher website
Google Scholar
Abstract
Basement membranes (BMs) are specialized extracellular matrix (ECM) structures essential for organ morphogenesis, architecture, and function. BM composition and properties vary between tissues, developmental stages, and disease states, and there is only a rudimentary understanding of BM dynamics. Here, we introduce a versatile mouse model carrying a multifunctional dual-color fluorescence tagged allele with knockout potential for the fundamental BM component type IV collagen alpha 1 (COL4A1). This allele enables the characterization of cell type- and time-specific contributions to BMs and the generation of a conditional Col4a1 null allele. We demonstrate the utility of this unique genetic resource in providing clinically relevant insights for individuals with Gould syndrome – a multisystem disorder caused by COL4A1 and COL4A2 mutations. We show active COL4A1 turnover in postnatal cerebrovascular BMs, identifying a potential interventional window for cerebrovascular manifestations associated with Gould syndrome. We also demonstrate that heterozygous Col4a1 deletion is significantly less pathogenic than dominant Col4a1 missense mutations, which has important implications for gene therapy.
Funding Information
  • National Institutes of Health (1R21NS133610, 1RF1NS128217)
  • National Institute of Neurological Disorders and Stroke
  • All May See Foundation
  • National Eye Institute (P30 EY002162)
  • Research to Prevent Blindness

This publication has 79 references indexed in Scilit: